![James Scibetta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Scibetta
Directeur Général chez
VectorY BV
Profil
James S.
Scibetta currently works at VectorY BV, as Chief Executive Officer & Director from 2024.
Mr. Scibetta also formerly worked at Maverick Therapeutics, Inc., as Chief Executive Officer & Director from 2017 to 2021, ImmuneID, Inc., as President, CEO, Treasurer & Director from 2021 to 2023, Nephros, Inc., as Chairman from 2007 to 2013, Labopharm, Inc., as Director from 2001 to 2008, Aquestive Therapeutics, Inc., as Independent Director from 2017 to 2022, Matinas BioPharma Holdings, Inc., as Independent Director from 2013 to 2025, Bioenvision, Inc., as Chief Financial Officer from 2006 to 2007, Pacira Biosciences, Inc., as President from 2016 to 2017, and Merrimack Pharmaceuticals, Inc., as Chief Financial Officer & Executive Vice President from 1998 to 2006.
Mr. Scibetta received his undergraduate degree from Wake Forest University and Masters Business Admin degree from the University of Michigan.
Postes actifs de James Scibetta
| Sociétés | Poste | Début |
|---|---|---|
VectorY BV
 VectorY BV BiotechnologyHealth Technology Develops vectorized antibody treatments for people with neurodegenerative diseases | Directeur Général | 16/12/2024 |
Anciens postes connus de James Scibetta
| Sociétés | Poste | Fin |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Directeur/Membre du Conseil | 21/01/2025 |
ImmuneID, Inc.
 ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Directeur Général | 01/01/2023 |
| AQUESTIVE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/06/2022 |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Directeur Général | 01/01/2021 |
| PACIRA BIOSCIENCES, INC. | Directeur Financier/CFO | 03/05/2016 |
Formation de James Scibetta
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Health Services |
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Nephros, Inc.
 Nephros, Inc. Medical SpecialtiesHealth Technology Develops and sells performance liquid purification filters used blood purification and other medical devices | Health Technology |
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
Matinas BioPharma Holdings, Inc.
 Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
VectorY BV
VectorY BV BiotechnologyHealth Technology Develops vectorized antibody treatments for people with neurodegenerative diseases | Health Technology |
